DSGN Design Therapeutics, Inc.

HealthcareBiotechnology
$14.10
▼ 3.09%
38
QScore Signal
Short
Confidence: MEDIUM
Long-Term
28
Short-Term
48

Value

30
P/E-12.43
8
P/B3.97
46
P/S0.00
70
EV/EBITDA-11.87
5

Growth

36
Revenue Growth0.0%
28
EPS Growth-38.6%
40
FCF Growth-25.6%
41

Momentum

84
12-Month Return288.4%
100
3-Month Return41.7%
100
1-Month Return11.3%
74
RSI (14)55.57
61
50/200 MABullish
75

Profitability

19
ROE-33.1%
45
ROA-30.3%
0
Gross Margin0.0%
14
Operating Margin0.0%
21
Net Margin0.0%
26
FCF Yield-6.1%
0

Risk

16
Beta1.74
35
60-Day Volatility72.1%
0

Generated 5/7/2026, 10:03:05 PM · How is this calculated?

QScore Analysis